Cited by 1,573Schizophrenia research and treatmentPsychological Testing and AssessmentMental Health and Psychiatry

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Keefe, R·2004·Schizophrenia Research

DOI 10.1016/j.schres.2003.09.011

Open this paper in CoChat — free account

Abstract

Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2003.09.011

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Untitled work
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617

Flagged first, then by citations

Show all 27 references

2 of the 27 references couldn’t be matched to a known paper.

Sorted by citations

The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
Fett, A.-K. J., Viechtbauer, W., Dominguez, M.-D.-G., Penn, D. L., van Os, J., & Krabbendam, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.001 · Cited by 1,833
Identification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Howes, O. D., McCutcheon, R. A., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050503 · Cited by 1,187
Overlooking the Obvious: A Meta-analytic Comparison of Digit Symbol Coding Tasks and Other Cognitive Measures in Schizophrenia
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.532 · Cited by 863
Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers
Clementz, B. A., Sweeney, J. A., Hamm, J. P., Ivleva, E. I., Ethridge, L. E., Pearlson, G. D., Keshavan, M. S., & Tamminga, C. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14091200 · Cited by 768
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 861
Domains of cognition and their assessment
Harvey, P. D. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/pharvey · Cited by 695
An Individualized Risk Calculator for Research in Prodromal Psychosis
Cannon, T. D., Yu, C., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Heinssen, R., Jeffries, C. D., Mathalon, D. H., McGlashan, T. H., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070890 · Cited by 574
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up
Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513
“Considering that domain scores were adjusted according to normative Italian scores for the BACS subtests in patients aged 18–70 years, we did not perform cognitive assessment in patients older than 70 years (Anselmetti et al., 2008).”
Influential
Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.
Reichenberg, A., & Harvey, P. D. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.5.833 · Cited by 558
Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone Intervention for Schizophrenia
Ben-Zeev, D., Brenner, C. J., Begale, M., Duffecy, J., Mohr, D. C., & Mueser, K. T. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu033 · Cited by 493
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial
Keefe, R. S. E., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., Meltzer, H. Y., Green, M. F., Miller, D. D., Canive, J. M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301072 · Cited by 472
Self-citation
Using Neuroplasticity-Based Auditory Training to Improve Verbal Memory in Schizophrenia
Fisher, M., Holland, C. M., Merzenich, M. M., & Vinogradov, S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08050757 · Cited by 428
The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-World Functioning, and Functional Capacity
Keefe, R. S. E., Poe, M. P., Walker, T. M., Kang, J. W., & Harvey, P. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.426 · Cited by 396
Defining a cognitive function decrement in schizophrenia
Keefe, R. S. E., Eesley, C. E., & Poe, M. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.003 · Cited by 389
Clinical Phenotypes of Psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)
Tamminga, C. A., Ivleva, E. I., Keshavan, M. S., Pearlson, G. D., Clementz, B. A., Witte, B. P., Morris, D. W., Bishop, J. R., Thaker, G. K., & Sweeney, J. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12101339 · Cited by 361
Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
Hill, S. K., Reilly, J. L., Keefe, R. S. E., Gold, J. M., Bishop, J. R., Gershon, E. S., Tamminga, C. A., Pearlson, G. D., Keshavan, M. S., & Sweeney, J. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12101298 · Cited by 354
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
KEEFE, R., HARVEY, P., GOLDBERG, T., GOLD, J., WALKER, T., KENNEL, C., & HAWKINS, K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.024 · Cited by 342
Treatment-Resistant Schizophrenia
Elkis, H. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.001 · Cited by 339
Combined Cognitive Remediation and Functional Skills Training for Schizophrenia: Effects on Cognition, Functional Competence, and Real-World Behavior
Bowie, C. R., McGurk, S. R., Mausbach, B., Patterson, T. L., & Harvey, P. D. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11091337 · Cited by 312
The Cognitive and Affective Structure of Paranoid Delusions: A Transdiagnostic Investigation of Patients With Schizophrenia Spectrum Disorders and Depression
Bentall, R. P., Rowse, G., Shryane, N., Kinderman, P., Howard, R., Blackwood, N., Moore, R., & Corcoran, R. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.1 · Cited by 295
Computerized Cognitive Training Restores Neural Activity within the Reality Monitoring Network in Schizophrenia
Subramaniam, K., Luks, T. L., Fisher, M., Simpson, G. V., Nagarajan, S. S., & Vinogradov, S. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.024 · Cited by 283
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance
Bowie, C. R., & Harvey, P. D. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.05.004 · Cited by 280
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042676 · Cited by 285
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Keefe, R. S. E., Sweeney, J. A., Gu, H., Hamer, R. M., Perkins, D. O., McEvoy, J. P., & Lieberman, J. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1061 · Cited by 280
The assessment of neuropsychological functioning in schizophrenia
Reichenberg, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/areichenberg · Cited by 278
Processing Speed Deficits in Schizophrenia: Reexamining the Evidence
Knowles, E. E. M., David, A. S., & Reichenberg, A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09070937 · Cited by 276
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Carbon, M., & Correll, C. U. (2014) · CNS Spectrums · doi:10.1017/s1092852914000601 · Cited by 281
Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version
Kaneda, Y., Sumiyoshi, T., Keefe, R. S. E., Ishimoto, Y., Numata, S., & Ohmori, T. (2007) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01725.x · Cited by 260
Psychomotor Slowing in Schizophrenia
Morrens, M., Hulstijn, W., & Sabbe, B. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl051 · Cited by 247
Neuroplasticity-Based Cognitive Training in Schizophrenia: An Interim Report on the Effects 6 Months Later
Fisher, M., Holland, C. M., Subramaniam, K., & Vinogradov, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn170 · Cited by 221
Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5
Barch, D. M., Bustillo, J., Gäebel, W., Gur, R., Heckers, S., Malaspina, D., Owen, M. J., Schultz, S. K., Tandon, R., Tsuang, M. T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.027 · Cited by 220
A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia
Couture, S. M., Granholm, E. L., & Fish, S. C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.020 · Cited by 241
Landslide recognition : identification, movement and courses
Dikau, R. (1996) · Wiley eBooks · Cited by 210
Cognitive Rehabilitation for Schizophrenia and the Putative Role of Motivation and Expectancies
Velligan, D. I., Kern, R. S., & Gold, J. M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj071 · Cited by 202
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Medial Temporal Lobe Structures and Hippocampal Subfields in Psychotic Disorders
Mathew, I. T., Gardin, T., Tandon, N., Eack, S. M., Francis, A., Seidman, L. J., Clementz, B. A., Pearlson, G. D., Sweeney, J. A., Tamminga, C. A., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.453 · Cited by 198
Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia
Sheffield, J. M., Repovš, G., Harms, M. P., Carter, C. S., Gold, J. M., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Godwin, D., & Barch, D. M. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.05.006 · Cited by 193
Treatment-Resistant Schizophrenia
Elkis, H., & Buckley, P. F. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.006 · Cited by 194
The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life
Bambini, V., Arcara, G., Bechi, M., Buonocore, M., Cavallaro, R., & Bosia, M. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.08.012 · Cited by 175
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170
Neurological and cognitive sequelae of COVID-19: a four month follow-up.
Mattioli, F., Stampatori, C., Righetti, F., Sala, E., Tomasi, C., & De Palma, G. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10579-6 · Cited by 160
Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique
Allott, K., Liu, P., Proffitt, T., & Killackey, E. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.001 · Cited by 165
Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
Grent-‘t-Jong, T., Groß, J., Goense, J. B. M., Wibral, M., Gajwani, R., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Schröder, T. N., et al. (2018) · eLife · doi:10.7554/elife.37799 · Cited by 174
Should cognitive impairment be included in the diagnostic criteria for schizophrenia?
Keefe, R. S. E. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00142.x · Cited by 171
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia
for the MEM-MD-29 Study Group, Lieberman, J. A., Papadakis, K., Csernansky, J., Litman, R., Volavka, J., Jia, X. D., & Gage, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.200 · Cited by 162
Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H. (2019) · Nutrients · doi:10.3390/nu11102362 · Cited by 170
“Cognitive functions were evaluated by a research psychiatrist using the Trail-Making Test [57], the Stroop test [58], and the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS) [59,60].”
Method
Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro
Silverstein, S. M., Berten, S., Olson, P. A., Paul, R. H., Williams, L. M., Cooper, N. J., & Gordon, E. (2007) · Behavior Research Methods · doi:10.3758/bf03192989 · Cited by 159
Differential Alterations of Auditory Gamma Oscillatory Responses Between Pre-Onset High-Risk Individuals and First-Episode Schizophrenia
Tada, M., Nagai, T., Kirihara, K., Koike, S., Suga, M., Araki, T., Kobayashi, T., & Kasai, K. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu278 · Cited by 164
A Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for Schizophrenia
Dickinson, D., Tenhula, W. N., Morris, S. E., Brown, C., Peer, J. E., Spencer, K., Li, L., Gold, J. M., & Bellack, A. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020264 · Cited by 160
The Relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to Functional Capacity and Real-world Functional Outcome
Keefe, R. S. E., Poe, M. P., Walker, T. M., & Harvey, P. D. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390500360539 · Cited by 155
Cognitive impairments in psychotic disorders: common mechanisms and measurement
Barch, D. M., & Sheffield, J. M. (2014) · World Psychiatry · doi:10.1002/wps.20145 · Cited by 154
Abnormal Responses to Monetary Outcomes in Cortex, but not in the Basal Ganglia, in Schizophrenia
Waltz, J. A., Schweitzer, J. B., Ross, T. J., Kurup, P. K., Salmeron, B. J., Rose, E. J., Gold, J. M., & Stein, E. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.126 · Cited by 151
The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
Speyer, H., Christian Brix Nørgaard, H., Birk, M., Karlsen, M., Storch Jakobsen, A., Pedersen, K., Hjorthøj, C., Pisinger, C., Gluud, C., Mors, O., et al. (2016) · World Psychiatry · doi:10.1002/wps.20318 · Cited by 153
Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long‐term course of illness
Bowie, C. R., Grossman, M., Gupta, M., Oyewumi, L. K., & Harvey, P. D. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12029 · Cited by 153
Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
Élie, D., Poirier, M., Chianetta, J. M., Durand, M., Gregoire, C. A., & Grignon, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100777 · Cited by 152
Symptom rating scales and outcome in schizophrenia
Mortimer, A. M. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.50.s7 · Cited by 150
Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia
Kochunov, P., Coyle, T. R., Rowland, L. M., Jahanshad, N., Thompson, P. M., Kelly, S., Du, X. M., Sampath, H., Bruce, H. A., Chiappelli, J., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2228 · Cited by 151
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Keefe, R. S. E., Malhotra, A. K., Meltzer, H. Y., Kane, J. M., Buchanan, R. W., Murthy, A. K., Sovel, M., Li, C., & GOLDMAN, R. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301499 · Cited by 146
Prediction of longitudinal functional outcomes in schizophrenia: The impact of baseline motivational deficits
Foussias, G., Mann, S. W., Zakzanis, K. K., van Reekum, R., Agid, O., & Remington, G. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.026 · Cited by 151
Cognitive Remediation for Treatment-Resistant Depression: Effects on Cognition and Functioning and the Role of Online Homework
Bowie, C. R., Gupta, M., Holshausen, K., Jokic, R., Best, M., & Milev, R. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31829c5030 · Cited by 136
Deficits in high- (>60 Hz) gamma-band oscillations during visual processing in schizophrenia
Grützner, C., Wibral, M., Sun, L., Rivolta, D., Singer, W., Maurer, K., & Uhlhaas, P. J. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00088 · Cited by 140
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?
Keefe, R. S. E., Buchanan, R. W., Marder, S. R., Schooler, N. R., Dugar, A., Zivkov, M., & Stewart, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr153 · Cited by 138
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
Poletti, S., Palladini, M., Mazza, M. G., LORENZO, R. D., Bollettini, I., Sara, B., Bravi, B., Ceciclio, B., Stefania, C., Valentina, C., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01346-9 · Cited by 152
Role of the gut microbiome in three major psychiatric disorders
Borkent, J., Ioannou, M., Laman, J. D., Haarman, B. C. M., & Sommer, I. E. (2022) · Psychological Medicine · doi:10.1017/s0033291722000897 · Cited by 139
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
The brief assessment of cognition in schizophrenia. Normative data for the Italian population
Anselmetti, S., Poletti, S., Ermoli, E., Bechi, M., Cappa, S., Venneri, A., Smeraldi, E., & Cavallaro, R. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0866-9 · Cited by 129
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127
Insight into neurocognitive dysfunction in schizophrenia.
Medalia, A., & Thysen, J. (2008) · Schizophrenia bulletin · doi:10.1093/schbul/sbm144 · Cited by 132
The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: Network meta-analyses of randomized controlled trials
Baldez, D. P., Biazus, T. B., Rabelo‐da‐Ponte, F. D., Nogaro, G. P., Martins, D. S., Kunz, M., & Czepielewski, L. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.028 · Cited by 140
Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition
Sheffield, J. M., Kandala, S., Tamminga, C. A., Pearlson, G. D., Keshavan, M. S., Sweeney, J. A., Clementz, B. A., Lerman-Sinkoff, D. B., Hill, S. K., & Barch, D. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0669 · Cited by 129
Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis
Lizano, P. L., Lutz, O., Xu, Y., Rubin, L. H., Paskowitz, L., Lee, A. M., Eum, S., Keedy, S., Hill, S. K., Reilly, J. L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00914-0 · Cited by 126
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium
Clementz, B. A., Parker, D., Trotti, R. L., McDowell, J. E., Keedy, S., Keshavan, M. S., Pearlson, G. D., Gershon, E. S., Ivleva, E. I., Huang, L.-Y., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab090 · Cited by 125
Association between cognitive deficits and suicidal ideation in patients with major depressive disorder
Pu, S., Setoyama, S., & Noda, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-12142-8 · Cited by 104
The relationship between sleep disturbance and cognitive impairment in mood disorders: A systematic review
Pearson, O. P., Uglik‐Marucha, N., Miskowiak, K. W., Cairney, S. A., Rosenzweig, I., Young, A. H., & Stokes, P. R. A. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.114 · Cited by 128
Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?
Medalia, A., Thysen, J., & Freilich, B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.007 · Cited by 116
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
Krystal, J. H., Kane, J. M., Correll, C. U., Walling, D. P., Leoni, M. J., Duvvuri, S., Patel, S., Chang, I., Iredale, P., Frohlich, L., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01990-0 · Cited by 115
Relationships Between Cognitive Deficits, Symptoms and Quality of Life in Schizophrenia
Savilla, K., Kettler, L. J., & Galletly, C. A. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802050512 · Cited by 112
Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function
Ogino, S., Miyamoto, S., Miyake, N., & Yamaguchi, N. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12088 · Cited by 113
Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders?
Giakoumatos, C. I., Tandon, N., Shah, J. L., Mathew, I. T., Brady, R. O., Clementz, B. A., Pearlson, G. D., Thaker, G. K., Tamminga, C. A., Sweeney, J. A., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.011 · Cited by 113
Quantifying Clinical Relevance in the Treatment of Schizophrenia
Correll, C. U., Kishimoto, T., Nielsen, J., & Kane, J. M. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.016 · Cited by 111
Meta-analysis of randomised controlled trials with N -acetylcysteine in the treatment of schizophrenia
Yolland, C. O. B., Hanratty, D., Neill, E., Rossell, S. L., Berk, M., Dean, O. M., Castle, D. J., Tan, E. J., Phillipou, A., Harris, A. W. F., et al. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419893439 · Cited by 112
General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro test battery
Williams, L. M., Whitford, T. J., Flynn, G., Wong, W. K. M., Liddell, B. J., Silverstein, S. M., Galletly, C. A., Harris, A. W. F., & Gordon, E. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.019 · Cited by 109
Mismatch Negativity and Cognitive Performance for the Prediction of Psychosis in Subjects with At-Risk Mental State
Higuchi, Y., Sumiyoshi, T., Seo, T., Miyanishi, T., Kawasaki, Y., & Suzuki, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054080 · Cited by 110
Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II)
Albert, N., Melau, M., Jensen, H., Emborg, C., Jepsen, J. R. M., Fagerlund, B., Gluud, C. N., Mors, O. N., Hjorthøj, C. R., & Nordentoft, M. (2017) · BMJ · doi:10.1136/bmj.i6681 · Cited by 109
The importance of measuring psychosocial functioning in schizophrenia
Brissos, S., Molodynski, A., Dias, V., & Figueira, M. L. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-18 · Cited by 108
Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction
Das, T., Ivleva, E. I., Wagner, A. D., Stark, C. E. L., & Tamminga, C. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.006 · Cited by 110
Hippocampal Volume Is Reduced in Schizophrenia and Schizoaffective Disorder But Not in Psychotic Bipolar I Disorder Demonstrated by Both Manual Tracing and Automated Parcellation (FreeSurfer)
Arnold, S. J. M., Ivleva, E. I., Gopal, T. A., Reddy, A. P., Jeon‐Slaughter, H., Sacco, C. B., Francis, A. N., Tandon, N., Bidesi, A. S., Witte, B. P., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu009 · Cited by 109
Motivational Interviewing to Increase Cognitive Rehabilitation Adherence in Schizophrenia
Fiszdon, J. M., Kurtz, M. M., Choi, J., Bell, M. D., & Martino, S. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv143 · Cited by 104
Motivational deficits as the central link to functioning in schizophrenia: A pilot study
Foussias, G., Mann, S. W., Zakzanis, K. K., van Reekum, R., & Remington, G. J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.020 · Cited by 103
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia
Davidson, M., Saoud, J. B., Staner, C., Noël, N., Luthringer, E., Werner, S., Reilly, J. G., Schaffhauser, J.-Y., Rabinowitz, J., Weiser, M., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17010122 · Cited by 104
A Brief Cognitive Assessment Tool for Schizophrenia: Construction of a Tool for Clinicians
Hurford, I. M., Marder, S. R., Keefe, R. S. E., Reise, S. P., & Bilder, R. M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp095 · Cited by 108
Cognitive performances associate with measures of white matter integrity in bipolar disorder
Poletti, S., Bollettini, I., Mazza, E., Locatelli, C., Radaelli, D., Vai, B., Smeraldi, E., Colombo, C., & Benedetti, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.030 · Cited by 102
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia
Pino, Ó., Guilera, G., Rojo, E., Gómez‐Benito, J., Bernardo, M., Crespo‐Facorro, B., Cuesta, M. J., Franco, M., Martínez‐Arán, A., Segarra, N., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.012 · Cited by 103
Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia
Fernández-Egea, E., Vértes, P. E., Flint, S. M., Turner, L., Mustafa, S. J., Hatton, A., Smith, K. G. C., Lyons, P., & Bullmore, E. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155631 · Cited by 106
Demographic and clinical correlates of substance use disorders in first episode psychosis
Brunette, M. F., Mueser, K. T., Babbin, S. F., Meyer-Kalos, P., Rosenheck, R. A., Correll, C. U., Cather, C., Robinson, D. G., Schooler, N. R., Penn, D. L., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.039 · Cited by 101
Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis — Findings from the Longitudinal Youth at Risk Study (LYRIKS)
Lim, J., Rekhi, G., Rapisarda, A., Lam, M., Kraus, M., Keefe, R. S. E., & Lee, J. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.007 · Cited by 103
Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment
Morrison, G. E., Simone, C. M., Ng, N. F., & Hardy, J. L. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01652 · Cited by 100
Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy
Choi, K., Wykes, T., & Kurtz, M. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107359 · Cited by 99

Authors: Keefe, R.
Affiliations: Duke University (US)
Corresponding author: Keefe, R
ORCID: Keefe, R
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2004-06-01
Volume: 68
Issue: 2-3
Pages: 283-297
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2003.09.011
OpenAlex: W2008062633
Cited by: 1,573
References: 27
Citations by year: 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
FWCI: 4.09
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: Brief Assessment of Cognition in Schizophrenia, schizophrenia
MeSH terms: Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks